Feature Image for Management of Acute Myeloid Leukemia in 2020

Management of Acute Myeloid Leukemia in 2020: A Paradigm Shift for Older Adults? (R2P SPOC)

Originally presented February 26, 2020 as part of the UNC Cancer Network Research to Practice Lecture Series. Course expired April 1, 2021.

This is a Non-Credit course and does NOT offer continuing education credits.

Presenter

Photo of Joshua Zeidner, MD

Joshua Zeidner, MD
Assistant Professor
Clinical Research
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Management of Acute Myeloid Leukemia in 2020:
A Paradigm Shift for Older Adults?

Dr. Joshua Zeidner will discuss updates in the diagnostic testing and prognostic subclassifications of AML which drive therapeutic decisions. This presentation will highlight perceived paradigm shifts for AML and older adults.

Learning Objectives

  • Discuss pathogenesis/etiology of AML
  • Explain diagnostic testing in AML
  • Describe management of AML in older patient populations in the context of recent drug approvals

Credits Offered

General Participation

Requirements

To receive credit for this course, you must:

  • Watch a lecture video recording.
  • Complete the lecture post test and obtain a passing score of 80% or higher.
  • Complete the course evaluation.
  • Select credit type.

Estimated course completion time: 1 hour
Estimated course completion time: 1 hour

Accreditation

This is a Non-Credit course and does NOT offer continuing education credits.

Disclaimer

Please note: This course was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. Questions about personal health should always be referred to a physician or other health care professional.